SYNAPTICS Inc — Director's Dealing 2015

Oct 28, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SYNAPTICS Inc (SYNA)
CIK: 0000817720
Period of Report: 2015-10-23

Reporting Person: Deutsch Scott (SVP of Worldwide Sales)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-10-23	Common Stock	A	6000	$0.00	Acquired	10189	Direct
2015-10-23	Common Stock	A	5381	$0.00	Acquired	15570	Direct
2015-10-23	Common Stock	F	2807	$89.29	Disposed	12763	Direct
2015-10-26	Common Stock	S	1474	$85.4484	Disposed	11289	Direct
2015-10-26	Common Stock	S	1000	$86.4025	Disposed	10289	Direct
2015-10-26	Common Stock	S	100	$88.32	Disposed	10189	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-10-23	Employee Stock Option (Right to Buy)	$89.29	A	4100	Acquired	2022-10-23	Common Stock (4100)	Direct

Footnotes

F1: One-third of the total number of deferred stock units shall vest on each anniversary following the vesting commencement date of 10/31/2015, until fully vested on 10/31/2018.

F2: Reflects shares released October 23, 2015 in connection with the vesting of performance-based market stock units granted on October 28, 2013 and October 24, 2014.

F3: Represents shares of common stock withheld by the Issuer to satisfy certain tax withholding obligations associated with the vesting of performance-based market stock units.

F4: The shares were sold pursuant to a 10b5-1 Trading Plan dated February 20, 2015.

F5: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $85.00 to $85.99,
inclusive. The reporting person undertakes to provide to Synaptics Incorporated (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F6: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $86.03 to $87.00,
inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F7: 1/12th of the total number of shares subject to the option shall vest and become exercisable each quarter following the October 23, 2015 date of grant, until fully vested on October 23, 2018.